Hmmm, hope you're right, but remember the guidance is for "underlying" npat - so plenty of wriggle room. Unfortunately shareholders can't spend "underlying dividends", only actual ones ...
As for "strategic reviews", one wonders what exactly the Board and executive management are doing on a day-to-day basis if not identifying and taking advantage of strategic opportunities?
- Forums
- ASX - By Stock
- ANG
- Ann: CEO Transition Timing Update
Ann: CEO Transition Timing Update, page-4
-
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ANG (ASX) to my watchlist
|
|||||
Last
61.0¢ |
Change
0.010(1.67%) |
Mkt cap ! $351.9M |
Open | High | Low | Value | Volume |
61.0¢ | 61.3¢ | 61.0¢ | $129.9K | 212.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 70241 | 60.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
61.0¢ | 24894 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 100604 | 0.605 |
6 | 83005 | 0.600 |
4 | 64669 | 0.595 |
5 | 39220 | 0.590 |
3 | 46350 | 0.585 |
Price($) | Vol. | No. |
---|---|---|
0.610 | 39113 | 2 |
0.615 | 49862 | 3 |
0.620 | 172523 | 6 |
0.625 | 6650 | 1 |
0.630 | 11437 | 3 |
Last trade - 10.14am 12/07/2024 (20 minute delay) ? |
Featured News
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
ANG (ASX) Chart |